$HDSN

Hudson Technologies Q2 Earnings Call Highlights

Hudson Technologies (NASDAQ:HDSN) reported Q2 revenue of $78.3 million, up 8% year over year, with sales volume up 12% but average refrigerant selling price down 6%. Gross margin fell to 26% from 31% a year earlier. The company revised its FY2026 gross-margin target to the low-to-mid-20% range and said the Defense Logistics Agency re-awarded a five-year $210 million contract.

Original reporting
Published Aug 7, 2026, 2:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 2:13 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Hudson Technologies Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$HDSNNeutralMed
01

Why it matters

The call combines (1) a revised full-year gross-margin outlook, (2) Q2 margin compression and cost drivers (ERP optimization, legal, staffing/consulting), (3) a resolved Defense Logistics Agency re-award worth $210M over five years, and (4) operational disruption from a June tornado with insurance covering restoration expenses.

02

Market read

Traders get a fresh read on margin risk (guidance cut and cost inflation), offset by a major government contract re-award and ongoing expansion of less cyclical recovery and services revenue.

03

What to watch

The DLA contract re-award followed a competitor challenge, so traders may underweight execution risk and overemphasize the headline contract value without details on margin contribution.

Relevance 7/10Novelty 7/10Timing: today’s earnings call highlights, including revised full-year gross-margin target

Background

Hudson Technologies is a refrigerant management and sustainability solutions provider, with revenue tied to refrigerant recovery, reclamation, and services, plus exposure to refrigerant pricing and facility uptime.

Company-level read

Ticker impact

$HDSNNeutralMedium confidence
Context

Hudson revised its 2026 gross-margin target to the low-to-mid-20% range and reported Q2 revenue, margin, and DLA contract re-award details.

Expected impact

Likely choppy reaction risk: margin outlook cut may weigh, but the $210M five-year DLA award and cash/no-debt profile can offset.

Evidence & confidence

The article provides concrete Q2 financials (revenue up, gross margin down), a specific full-year gross-margin revision, and a named contract award, which together drive a fresh valuation and risk read for HDSN.

Market effects

Refrigerant recovery and reclamation demand signals (pricing stabilization, growth in recovered volumes) may influence sentiment across refrigerant sustainability peers.

Illinois tornado recovery and insurance coverage highlight operational resilience risk for facilities in severe-weather regions.

No direct global macro linkage beyond ongoing inflationary pressure and refrigerant market dynamics.

Counterpoint

Gross margin weakness may be temporary, with ERP optimization costs expected to decline in the second half and pricing stabilizing sequentially.

Key entities

  • Hudson Technologies

    NASDAQ-listed refrigerant recovery and reclamation company that revised 2026 gross-margin guidance and reported Q2 results and a DLA contract re-award.

  • Defense Logistics Agency (DLA)

    Re-awarded Hudson a five-year, $210 million contract after a competitor challenge and review period.

  • Icorium

    Planned technology partner to scale extractive distillation for difficult refrigerant separations.

Related articles

$HDSNMed

Hudson Technologies (NASDAQ:HDSN) Surprises With Q2 CY2026 Sales

Hudson Technologies (NASDAQ:HDSN) reported Q2 CY2026 revenue of $78.35 million, up 7.5% year on year and 5.6% above Wall Street estimates, according to the company. GAAP EPS was $0.12, below consensus and down from $0.23 a year earlier. Management cited selling-season growth despite HFC price weakness and inflation. Shares fell 1.5% to $6.12 after the release.

$HDSNMed

HUDSON TECHNOLOGIES INC /NY (HDSN): Results of Operations and Financial Condition

HUDSON TECHNOLOGIES INC /NY (HDSN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622080d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 HUDSON TECHNOLOGIES REPORTS SECOND quarter 2026 reSults Second quarter revenue grew 8% driven by strong volume Posts trailing twelve month double-digit volume growth Operations fully restored at tornado impacted facility

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.

$DBXMed

Dropbox Shares Decline Despite Earnings Beat as Revenue Growth Disappoints

Dropbox (DBX) shares fell about 5% premarket to around $32.80 after Q2 2026 results. The company reported adjusted EPS of $0.75 vs $0.74 expected and revenue of $631.5M vs about $627M, but revenue rose only 0.9% year over year. Non-GAAP operating margin improved to 39.7%. Paying users reached 18.19M. William Blair upgraded to Market Perform, while consensus remains Sell.

$HLMedAI 8/10

Hecla Mining Q2 Earnings Call Highlights

Hecla Mining reported Q2 financial and operating updates. The company ended the quarter with $483 million cash, about $472 million net cash, and an essentially undrawn $225 million revolver. It projected 2026 free cash flow of about $500 million at $50 silver and $3,500 gold, and raised Greens Creek silver guidance to 8.0-8.3 million ounces. Production guidance was adjusted for Lucky Friday and Keno Hill.

$RCELHighAI 9/10

Avita Medical Shares Surge After Record Second-Quarter Performance

Avita Medical (NASDAQ:RCEL) shares rose about 21.7% in premarket after it reported record Q2 results. Revenue was $21.7M, up 18% YoY and about 8% above estimates. Adjusted loss per share narrowed to $0.25 vs $0.30 expected. Full-year 2026 revenue guidance raised to $86M-$89M and cash-flow breakeven targeted for Q4 2026. BTIG upgraded to Buy with a $7.00 target.